|
Prince Edward Island is developing world class strengths and capacity in several areas that provide a base for the development of BioScience products and processes.
The BioScience industry in Prince Edward Island is experiencing rapid growth.
Prince Edward Island is widely recognized for its expertise in the areas of, veterinary medicine, aquaculture, agriculture and human health. There is also considerable research expertise and capability in crop genetics, diagnostics and bio-informatics, along with commercial activity in tissue culture and field crop improvements.
Through business expansion, contract research, joint ventures and partnerships, Prince Edward Island's BioScience industry is experiencing rapid growth, projected to be over 50 % annually for the next five years. Areas such as veterinary vaccines, point-of-care diagnostics, human therapeutics, medical devices and the commercial development of bio-based economy products are starting to flourish.
 Borden Ladner Gervais LLP | www.blgcanada.com
Borden Ladner Gervais LLP is a leading full-service law firm with expertise in all areas of intellectual property law, commercial law and litigation. BLG is a leader in Canadian intellectual property practice with a National Biotechnology Group consisting of lawyers and patent agents with diverse scientific backgrounds and in-depth knowledge of the industry. BLG professionals routinely form client-specific teams to provide the scientific and legal support required for even the most complex intellectual property issues and commercial transactions. BLG professionals maintain regular contact with clients and contacts across Canada and abroad. As a firm, BLG is committed to supporting innovation in the Maritimes.
Prince Edward Island Bioalliance | www.peibioalliance.com
 The Prince Edward Island BioAlliance is the cluster of individuals and organizations dedicated to building the bioscience-based economic sector in PEI, with an emphasis on collaborative initiatives in research, business, education, and supporting infrastructure. The PEI Bioscience Cluster provides a location of choice for companies engaged in the research, development, and commercialization of bioactives-based human, animal, and fish health and nutrition. Our focus is on research & product development of bioactive compounds derived from natural sources, terrestrial and marine; animal health and nutrition products; fish health products; human health, including the treatment of diseases of aging, obesity, infection and immunity; and human and animal health diagnosis. |
The
Bruker BioSpin Group of companies develop,
manufacture and supply technology to research
establishments, commercial enterprises and
multi-national corporations across countless
industries and fields of expertise. Bruker
BioSpin is continuing to revolutionize the
design, manufacture and distribution of life
science, process control and analytical research
tools based on magnetic resonance core technology.
At
Indena we believe that an in-depth knowledge
in active ingredients derived from medicinal
plants and the search for excellence at all
times are crucial commitments to serving
our customers in pharmaceuticals, health
foods and cosmetics. Research and production
technologies are the main focus of our mission
and the way we create a "value difference" for
our partners. And we've got more than 80
years of experience to prove it. 
Unigen is a leading natural products research
and development company and proprietary ingredients
supplier. The company is dedicated to the discovery
of botanically derived therapeutic compounds
that address consumer health needs and help
improve the quality of human life. Its research
and discovery process includes extensive work
at both the human cell and gene level.
We are an Eastern Canadian pharmaceutical/biologic
manufacturer with over 35 years of experience
serving a global customer base. BioVectra
provides small to large scale custom manufacturing
of advanced intermediates, active pharmaceutical
ingredients and biologics along with a complement
of core products targeted toward bioprocessing. 
Neurodyn Inc., a Canadian
biotechnology company, is working to develop
and market products for early detection and
treatment of neurodegenerative diseases. The
company's patent-pending animal model of human
neurodegenerative diseases, including ALS (amyotrophic
lateral sclerosis), Parkinson's and Alzheimer's
disease, is based on the identification of
novel environmental neurotoxins. Neurodyn's
animal model faithfully replicates the neurodegenerative
process from its earliest stages providing
an ideal test platform for the preclinical
evaluation of potential new diagnostics and
therapeutics for these human neurological diseases.
Nautilus Biosciences develops sustainable production methods for selected marine bioactive compounds and identify new drugs and drug leads from marine organisms. Nautilus Develops highly innovative methods to produce valuable compounds, which hold enormous potential for anti-inflammatory and anti-cancer therapeutic benefits, and are currently only available through harvesting on threatened coral reefs. 
